W. Rath, Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.147, issue.1, p.1520, 2009.
DOI : 10.1016/j.ejogrb.2009.06.018

J. Villar, E. Valladares, D. Wojdyla, N. Zavaleta, G. Carroli et al., Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America, Lancet, vol.367, p.18191829, 2006.

F. Goffinet, F. Mercier, V. Teyssier, F. Pierre, M. Dreyfus et al., Postpartum haemorrhage: recommendations for clinical practice by the CNGOF, J Gynecol Obstet Fertil, vol.33, p.268274, 2005.

W. Prendiville, D. Elbourne, and I. Chalmers, The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials, BJOG: An International Journal of Obstetrics and Gynaecology, vol.55, issue.1, p.316, 1988.
DOI : 10.1016/S0140-6736(60)92082-1

L. Low, J. Bailey, E. Sacks, L. Medina, and H. Piñeda, Postpartum Hemorrhage Prevention: A Case Study in Northern Rural Honduras, Journal of Midwifery & Women's Health, vol.53, issue.1, p.16, 2008.
DOI : 10.1016/j.jmwh.2007.08.014

P. Van-dongen, M. Verbruggen, A. De-groot, J. Van-roosmalen, J. Sporken et al., Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.77, issue.2, p.181187, 1998.
DOI : 10.1016/S0301-2115(97)00260-1

D. Leduc, V. Senikas, A. Lalonde, C. Ballerman, A. Biringer et al., Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage, Journal of Obstetrics and Gynaecology Canada, vol.31, issue.10, p.980993, 2009.
DOI : 10.1016/S1701-2163(16)34329-8

S. Barton and A. Jackson, The safety and efficiency of carbetocin to control uterine bleeding following caesarean section, Prenatal and Neonatal Medicine, vol.1, p.185, 1996.

F. Borruto, A. Treisser, and C. Comparetto, Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial, Arch Gynecol Obstet, vol.280, p.707712, 2009.

L. Su, Y. Chong, and M. Samuel, Carbetocin for preventing postpartum haemorrhage, Cochrane Database Syst Rev, vol.102, issue.3, p.5457, 2012.
DOI : 10.1002/14651858.CD005457.pub3

G. Larciprete, C. Montagnoli, M. Frigo, V. Panetta, C. Todde et al., Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage, Journal of Prenatal Medicine, vol.7, p.1218, 2013.
DOI : 10.11138/jpm/2013.7.1.012

G. Attilakos, D. Psaroudakis, J. Ash, R. Buchanan, C. Winter et al., Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial, BJOG: An International Journal of Obstetrics & Gynaecology, vol.116, issue.8, p.929936, 2010.
DOI : 10.1111/j.1471-0528.2010.02585.x

D. Bonis, M. Torricelli, M. Leoni, L. Berti, P. Ciani et al., Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage, The Journal of Maternal-Fetal & Neonatal Medicine, vol.53, issue.6, p.732735, 2012.
DOI : 10.1038/clpt.1992.103

M. Moertl, S. Friedrich, J. Kraschl, C. Wadsack, U. Lang et al., Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial, BJOG: An International Journal of Obstetrics & Gynaecology, vol.52, issue.3, p.13491356, 2011.
DOI : 10.1111/j.1471-0528.2011.03022.x

C. Holleboom, J. Van-eyck, S. Koenen, I. Kreuwel, F. Bergwerff et al., Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands, Archives of Gynecology and Obstetrics, vol.152, issue.4, p.11111117, 2013.
DOI : 10.1007/s00404-012-2693-8

G. Triopon, A. Goron, J. Agenor, G. Aya, A. Chaillou et al., Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin, Gynecol Obstet Fertil, vol.38, p.729734, 2010.

D. A. García, G. Garcia-contreras, F. Constantino-casas, P. Nevarez-sida, A. Lopez-gonzalez et al., PIH6 ECONOMIC EVALUATION OF CARBETOCINE FOR THE PREVENTION OF UTERINE ATONY IN PATIENTS WITH RISK FACTORS IN MEXICO, Value in Health, vol.9, issue.6, pp.254-254, 2006.
DOI : 10.1016/S1098-3015(10)63364-5

L. Higgins, J. Mechery, and A. Tomlinson, Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin?, Journal of Obstetrics and Gynaecology, vol.137, issue.3, p.732739, 2011.
DOI : 10.3109/01443615.2011.595982

C. Dupont, S. Touzet, C. Colin, C. Deneux-tharaux, M. Rabilloud et al., Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France, International Journal of Obstetric Anesthesia, vol.18, issue.4, p.320327, 2009.
DOI : 10.1016/j.ijoa.2009.02.017

URL : https://hal.archives-ouvertes.fr/hal-00539365

W. Rath, Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.147, issue.1, p.1520, 2009.
DOI : 10.1016/j.ejogrb.2009.06.018

J. Villar, E. Valladares, D. Wojdyla, N. Zavaleta, G. Carroli et al., Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America, Lancet, vol.367, p.18191829, 2006.

F. Goffinet, F. Mercier, V. Teyssier, F. Pierre, M. Dreyfus et al., Postpartum haemorrhage: recommendations for clinical practice by the CNGOF, J Gynecol Obstet Fertil, vol.33, p.268274, 2005.

W. Prendiville, D. Elbourne, and S. Mcdonald, Active versus expectant management in the third stage of labour, Cochrane Database Syst Rev, issue.3, p.7, 2009.

L. Low, J. Bailey, E. Sacks, L. Medina, and H. Piñeda, Postpartum Hemorrhage Prevention: A Case Study in Northern Rural Honduras, Journal of Midwifery & Women's Health, vol.53, issue.1, p.16, 2008.
DOI : 10.1016/j.jmwh.2007.08.014

W. Prendiville, D. Elbourne, and I. Chalmers, The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials, BJOG: An International Journal of Obstetrics and Gynaecology, vol.55, issue.1, p.316, 1988.
DOI : 10.1016/S0140-6736(60)92082-1

P. Van-dongen, M. Verbruggen, A. De-groot, J. Van-roosmalen, J. Sporken et al., Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.77, issue.2, p.181187, 1998.
DOI : 10.1016/S0301-2115(97)00260-1

D. Leduc, V. Senikas, A. Lalonde, C. Ballerman, A. Biringer et al., Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage, Journal of Obstetrics and Gynaecology Canada, vol.31, issue.10, p.980993, 2009.
DOI : 10.1016/S1701-2163(16)34329-8

J. Pritchard, F. Mercier, V. Tessier, F. Pierre, M. Dreyfus et al., Blood volume changes in pregnancy and the puerperium, Am J Obstet Gynecol, vol.84, p.127182, 1962.

C. Combs, M. Andrew, E. L. Murphy, and R. K. Laros, Factors Associated Cesarean with Hemorrhage in Deliveries, Obstetrical & Gynecological Survey, vol.46, issue.6, 1991.
DOI : 10.1097/00006254-199106000-00011

M. Palot, M. Hémorragie-de-la-délivrancecolle, F. Péquignot, and E. Jougla, Prise en charge hospitalière initiale Maternal mortality in France: frequency, trends and causes, J Gynécologie Obstétrique Biol Reprod, vol.616730, p.768775, 1997.

F. Goffinet, G. Lévy, B. Carbonne, F. Courtois, and P. Dosquet, Hémorragies du postpartum immédiat : méthode utilisée et questions abordées, J Gynecol Obstet Biol Reprod, vol.33, issue.8, 2004.

M. Mccormick, H. Sanghvi, B. Kinzie, and N. Mcintosh, Preventing postpartum hemorrhage in low-resource settings, International Journal of Gynecology & Obstetrics, vol.344, issue.3, p.267275, 2002.
DOI : 10.1016/S0020-7292(02)00020-6

F. Goffinet, G. Lévy, B. Carbonne, F. Courtois, and P. Dosquet, Hémorragies du postpartum immédiat : méthode utilisée et questions abordées, J Gynecol Obstet Biol Reprod, vol.33, issue.8, 2004.

F. Pierre, J. Bertrand, C. Berger, J. Levy, and J. Melchior, Délivrance normale et pathologique, 1985.

S. Wu, M. Kocherginsky, J. Hibbard, S. Clark, P. Koonings et al., Abnormal placentation: twenty-year analysis Placenta previa/accreta and prior cesarean section, Am J Obstet Gynecol. Obstet Gynecol, vol.19266, issue.20, p.145814618992, 1985.

F. Goffinet, G. Lévy, B. Carbonne, F. Courtois, and P. Dosquet, Hémorragies du postpartum immédiat : méthode utilisée et questions abordées, J Gynecol Obstet Biol Reprod, vol.33, issue.8, 2004.

N. Prata, S. Hamza, S. Bell, D. Karasek, F. Vahidnia et al., Inability to predict postpartum hemorrhage: insights from Egyptian intervention data, BMC Pregnancy and Childbirth, vol.17, issue.1, p.97, 2011.
DOI : 10.1016/j.ijgo.2004.05.013

D. Subtil, A. Sommé, E. Ardiet, S. Depret-mosser, C. Paterson et al., Postpartum hemorrhage: frequency, consequences in terms of health status, and risk factors before delivery Neonatal and maternal morbidity in relation to the length of the second stage of labour, J Gynecol Obstet Biol Reprod. Br J Obstet Gynaecol, vol.3399, p.381385, 1992.

M. Waterstone, S. Bewley, C. Wolfe, C. Paterson, and N. Saunders, Incidence and predictors of severe obstetric morbidity: case-control study Risk factors for major obstetric haemorrhage, BMJ. Eur J Obstet Gynecol Reprod Biol, vol.32248, p.1518, 1993.

S. Haeri and G. Dildy, Maternal Mortality From Hemorrhage, Seminars in Perinatology, vol.36, issue.1, p.4855, 2012.
DOI : 10.1053/j.semperi.2011.09.010

F. Golfier and F. Golfier, Recommandations pour la pratique clinique de la CNGOF

S. Technique-opératoire-de-la-césarienne-liou, C. Chen, S. Wong, K. Wong, T. Thomas et al., Ventricular tachycardia after oxytocin injection in patients with prolonged Q-T interval syndrome--report of two cases Editorial Board of the Confidential Enquiries into Maternal Deaths in the United Kingdom Maternal deaths from anaesthesia. An extract from Why mothers die 1997-1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom Facteurs de risques au cours du travail et prévention clinique et pharmacologique de l'hémorragie du post-partum, Prophylactic use of ergot alkaloids in the third stage of labour, pp.8695-314952, 1998.

Y. Hayashi, T. Ibe, H. Kawato, N. Futamura, S. Koyabu et al., Postpartum Acute Myocardial Infarction Induced by Ergonovine Administration, Internal Medicine, vol.42, issue.10, p.983986, 2003.
DOI : 10.2169/internalmedicine.42.983

F. Goffinet, B. Haddad, B. Carbonne, E. Sebban, E. Papiernik et al., Practical use of sulprostone in the treatment of hemorrhages during delivery Postpartum misoprostol for preventing maternal mortality and morbidity Fazel MR, Mansoure-Samimi, Esmaeil-Fakharian. A comparison of rectal misoprostol and intravenous oxytocin on hemorrhage and homeostatic changes during cesarean section Postpartum hemorrhage in the developed world: whither misoprostol?, J Gynecol Obstet Biol Reprod. Cochrane Database Syst Rev. Middle East J Anesthesiol. Am J Obstet Gynecol, vol.24722208, issue.39, pp.209216-209253, 1995.

J. Blum, B. Winikoff, S. Raghavan, R. Dabash, M. Ramadan et al., Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial, The Lancet, vol.375, issue.9710, p.217223, 2010.
DOI : 10.1016/S0140-6736(09)61923-1

F. Mercier, M. Bonnet, A. Bischofberger, O. Irion, S. Gbrien et al., Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage Prise en charge multidisciplinaire des hémorragies du post-partum : nouvelles stratégies. Revue médicale suisse Prediction of peripartum hysterectomy and end organ dysfunction in major obstetric haemorrhage, Curr Opin Anaesthesiol. Eur J Obstet Gynecol Reprod Bio, vol.237153, pp.310316-43334339, 2010.

D. Thomas, Facilities for blood salvage (cell saver technique) must be available in every obstetric theatre, International Journal of Obstetric Anesthesia, vol.14, issue.1, p.4850, 2005.
DOI : 10.1016/j.ijoa.2004.09.001

J. Geoghegan, J. Daniels, P. Moore, P. Thompson, K. Khan et al., Cell salvage at caesarean section: the need for an evidence-based approach The introduction of intraoperative cell salvage in obstetric clinical practice: a review of the available evidence, BJOG. Eur J Obstet Gynecol Reprod Biol, vol.116159, issue.1, pp.7437-471925, 2009.

B. Charbit, L. Mandelbrot, E. Samain, G. Baron, B. Haddaoui et al., The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage, Journal of Thrombosis and Haemostasis, vol.25, issue.2, 2007.
DOI : 10.1111/j.1538-7836.2007.02297.x

Z. Alfirevic, D. Elbourne, S. Pavord, A. Bolte, H. Van-geijn et al., Use of Recombinant Activated Factor VII in Primary Postpartum Hemorrhage, Obstetrics & Gynecology, vol.110, issue.6, p.157162, 2000.
DOI : 10.1097/01.AOG.0000288515.48066.99

T. Kobayashi, M. Nakabayashi, A. Yoshioka, M. Maeda, and T. Ikenoue, Recombinant activated factor VII (rFVIIa/NovoSeven??) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan, International Journal of Hematology, vol.58, issue.1, p.5763, 2012.
DOI : 10.1007/s12185-011-0974-9

A. Huber, L. Raio, L. Alberio, F. Ghezzi, D. Surbek et al., Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study Tranexamic acid for preventing postpartum haemorrhage, J Perinat Med. Cochrane Database Syst Rev, vol.40, issue.7, pp.4349-54, 2010.

J. Xu, W. Gao, and Y. Ju, Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial, Archives of Gynecology and Obstetrics, vol.59, issue.2, p.463468, 2013.
DOI : 10.1007/s00404-012-2593-y

M. Gai, L. Wu, Q. Su, K. Tatsumoto, B. Jude et al., Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial High-dose tranexamic acid reduces blood loss in postpartum haemorrhage, R117. 58. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications, p.238240, 1993.

O. Leary and J. , Uterine artery ligation in the control of postcesarean hemorrhage

M. Tsirulnikov, C. B-lynch, A. Coker, A. Lawal, J. Abu et al., Immediate and long-term results The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported, Hemostatic suturing technique for uterine bleeding during cesarean delivery, p.751753372375129131, 1979.

W. Reich, M. Nechtow, S. Clark, J. Phelan, S. Yeh et al., Ligation of the internal iliac (hypogastric) arteries: a life-saving procedure for uncontrollable gynecologic and obstetric hemorrhage Hypogastric artery ligation for obstetric hemorrhage, J Int Coll Surg. Obstet Gynecol, vol.3666, issue.64, p.157168353356, 1961.

J. Zheng, X. Xiong, Q. Ma, X. Zhang, and M. Li, A new uterine compression suture for postpartum haemorrhage with atony, BJOG: An International Journal of Obstetrics & Gynaecology, vol.91, issue.3, p.370374, 2011.
DOI : 10.1111/j.1471-0528.2010.02809.x

T. Wong, Emergency peripartum hysterectomy: a 10-year review in a tertiary obstetric hospital, N Z Med J. Brown BJ, vol.124, issue.67, p.3439, 2011.

S. Pais, M. Glickman, P. Schwartz, E. Pingoud, R. Berkowitz et al., Embolization of pelvic arteries for control of postpartum hemorrhage Postpartum hemmorhage: prevention and treatment by arterial embolization and activated recombinant factor VII, Obstet Gynecol. Obstet Gynecol. Rev Médicale Suisse, vol.54554, pp.361365-68, 1979.

J. Delotte, S. Novellas, C. Koh, A. Bongain, and P. Chevallier, Obstetrical prognosis and pregnancy outcome following pelvic arterial embolisation for post-partum hemorrhage, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.145, issue.2, p.129132, 2009.
DOI : 10.1016/j.ejogrb.2009.03.013

C. Georgiou, Balloon tamponade in the management of postpartum haemorrhage: a review, BJOG: An International Journal of Obstetrics & Gynaecology, vol.259, issue.6, p.748757, 2009.
DOI : 10.1111/j.1471-0528.2009.02113.x

Y. Bakri, A. Amri, A. Jabbar, and F. , Tamponade-balloon for obstetrical bleeding, International Journal of Gynecology & Obstetrics, vol.86, issue.2, p.139142, 2001.
DOI : 10.1016/S0020-7292(01)00395-2

P. Raynal, . Bakri-balloon, G. Ortmeyer, B. Hollwitz, M. Lotz et al., The combination of intrauterine balloon tamponade and the B-Lynch procedure for the treatment of severe postpartum hemorrhage Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails Postpartum hemorrhage today: ICM/FIGO initiative, Sleth J-C. Postpartum haemorrhage and uterine balloon: time to revise the French guidelines, pp.540547-77243253, 2004.

A. Atke and H. Vilhardt, Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin, European Journal of Endocrinology, vol.115, issue.1
DOI : 10.1530/acta.0.1150155

A. Schramme, C. Pinto, J. Davis, C. Whisnant, M. Whitacre et al., Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows Actions of oxytocin and a long-acting carba oxytocin analog on the porcine myometrium in vitro and in vivo, Equine Vet J. Theriogenology. Am J Vet Res, vol.406540, issue.82, pp.658661-81400414430432, 1979.

T. Barth, K. Jost, I. Rychlík, G. Sweeney, A. Holbrook et al., Milk-ejecting and uterotonic activities of oxytocin analogues in rats, Endocrinol Exp, vol.9, issue.84, p.3542, 1975.

T. Pharmacokinetics-of-carbetocin-engstrøm, T. Barth, P. Melin, and H. Vilhardt, Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation, Current Therapeutic Research. Eur J Pharmacol, vol.47355, issue.86, pp.528540-85, 1990.

D. Hunter, P. Schulz, and W. Wassenaar, Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus, BJOG Int J Obstet Gynaecol. Clin Pharmacol Ther, vol.11852, issue.87, p.134913566067, 1992.

J. Silcox, P. Schulz, G. Horbay, and W. Wassenaar, Transfer of carbetocin into human breast milk, Obstet Gynecol, vol.82, p.456459, 1993.

D. Cordovani, M. Balki, D. Farine, G. Seaward, and J. Carvalho, Carbetocin at Elective Cesarean Delivery, Obstetric Anesthesia Digest, vol.33, issue.3, p.751757, 2012.
DOI : 10.1097/01.aoa.0000432368.86002.c5

S. Barton and A. Jackson, The safety and efficiency of carbetocin to control uterine bleeding following caesarean section, Prenatal and Neonatal Medicine, vol.1, p.185, 1996.

M. Boucher, G. Horbay, P. Griffin, Y. Deschamps, C. Desjardins et al., Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section, J Perinatol Off J Calif Perinat Assoc, vol.18, p.202207, 1998.

L. Su, Y. Chong, M. Samuel, S. Leung, P. Ng et al., Oxytocin agonists for preventing postpartum haemorrhage A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour, CD005457. 94, p.14591464, 2006.

F. Borruto, A. Treisser, and C. Comparetto, Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial, Arch Gynecol Obstet, vol.280, p.707712, 2009.

G. Attilakos, D. Psaroudakis, J. Ash, R. Buchanan, C. Winter et al., Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin, BJOG Int J Obstet Gynaecol. Gynecol Obstet Fertil, vol.11738, p.729734, 2010.

D. A. García, G. Garcia-contreras, F. Constantino-casas, P. Nevarez-sida, A. Lopez-gonzalez et al., PIH6 ECONOMIC EVALUATION OF CARBETOCINE FOR THE PREVENTION OF UTERINE ATONY IN PATIENTS WITH RISK FACTORS IN MEXICO, Value in Health, vol.9, issue.6, pp.254-254, 2006.
DOI : 10.1016/S1098-3015(10)63364-5

L. Su, Y. Chong, and M. Samuel, Carbetocin for preventing postpartum haemorrhage, Cochrane Database Syst Rev, vol.102, issue.3, p.5457, 2012.
DOI : 10.1002/14651858.CD005457.pub3

G. Larciprete, C. Montagnoli, M. Frigo, V. Panetta, C. Todde et al., Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage, Journal of Prenatal Medicine, vol.7, p.1218, 2013.
DOI : 10.11138/jpm/2013.7.1.012

C. Holleboom, J. Van-eyck, S. Koenen, I. Kreuwel, F. Bergwerff et al., Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands, Archives of Gynecology and Obstetrics, vol.152, issue.4, p.11111117, 2013.
DOI : 10.1007/s00404-012-2693-8

M. Boucher, G. Horbay, P. Griffin, Y. Deschamps, C. Desjardins et al., Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section, J Perinatol Off J Calif Perinat Assoc, vol.18, p.202207, 1998.

L. Low, J. Bailey, E. Sacks, L. Medina, and H. Piñeda, Postpartum Hemorrhage Prevention: A Case Study in Northern Rural Honduras, Journal of Midwifery & Women's Health, vol.53, issue.1, p.16, 2008.
DOI : 10.1016/j.jmwh.2007.08.014

I. Pisani, G. Tiralongo, G. Gagliardi, R. Scala, C. Todde et al., The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, p.139142, 2012.

L. Rosseland, T. Hauge, G. Grindheim, A. Stubhaug, and E. Langesaeter, Changes in Blood Pressure and Cardiac Output during Cesarean Delivery: The Effects of Oxytocin and Carbetocin Compared with Placebo, Anesthesiology, vol.119, p.541551, 2013.

O. Reyes and G. Gonzalez, Carbetocin Versus Oxytocin for Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia: A Double-Blind Randomized Controlled Trial, Journal of Obstetrics and Gynaecology Canada, vol.33, issue.11, p.10991104, 2011.
DOI : 10.1016/S1701-2163(16)35077-0

L. Higgins, J. Mechery, and A. Tomlinson, Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin?, Journal of Obstetrics and Gynaecology, vol.137, issue.3, p.732739, 2011.
DOI : 10.3109/01443615.2011.595982

A. James, S. Patel, W. Watson, Q. Zaidi, A. Mangione et al., An Assessment of Medical Resource Utilization and Hospitalization Cost Associated with a Diagnosis of Anemia in Women with Obstetrical Bleeding in the United States, Journal of Women's Health, vol.17, issue.8, p.12791284, 2008.
DOI : 10.1089/jwh.2007.0605